Impact of Dance Therapy on Parkinson's Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01428648|
Recruitment Status : Withdrawn (Recruitment slow)
First Posted : September 5, 2011
Last Update Posted : March 4, 2015
|Condition or disease||Intervention/treatment||Phase|
|Parkinson's Disease||Behavioral: Ballroom Dancing Classes||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Impact of Dance Therapy on Parkinson's Disease|
|Study Start Date :||August 2012|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||March 2013|
Active Comparator: intervention
group of patients receiving ballroom dancing classes
Behavioral: Ballroom Dancing Classes
bi-weekly, 12-Week ballroom dance classes
No Intervention: control
group of patients who will not receive dancing classes.
- Effect of ballroom dancing classes on motor function in patients with Parkinson's disease. [ Time Frame: 3 and 5 months ]The improvement in participant's motor function will be measured by the UPRS III score. The aim is to detect an 18-20% difference in UPDRS III scores among the two groups.
- Effect of ballroom dancing classes on depression in patients with Parkinson's disease. [ Time Frame: 3 and 5 months ]The improvement in participant's depression will be measured by the Hamilton Depression Scale.
- Effect of ballroom dancing classes on quality of life of patients with Parkinson's disease. [ Time Frame: 3 and 5 months ]The improvement in participant's quality of life will be measured by the Parkinson's Disease-39 questionnaire PDQ-39 scale.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01428648
|United States, Arkansas|
|University of Arkansas for Medical Sciences|
|Little Rock, Arkansas, United States, 72205|
|Principal Investigator:||Nancy Maalouf, MD||University of Arkansas|